Literature DB >> 22440813

Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse.

William S Wright1, Amit Singh Yadav, Robert M McElhatten, Norman R Harris.   

Abstract

The aim of this study was to characterize the microvascular flow abnormalities and oxygenation changes that are present following six months of hyperglycemia in the diabetic Ins2(Akita) mouse. Previous studies have shown decreased retinal blood flow in the first several weeks of hyperglycemia in rodents, similar to the decreases seen in the early stages of human diabetes. However, whether this alteration in the mouse retina continues beyond the initial weeks of diabetes has yet to be determined, as are the potential consequences of the decreased flow on retinal oxygenation. In this study, male Ins2(Akita) and age-matched C57BL/6 (non-diabetic) mice were maintained for a period of six months, at which time intravital microscopy was used to measure retinal blood vessel diameters, blood cell velocity, vascular wall shear rates, blood flow rates, and transient capillary occlusions. In addition, the presence of hypoxia was assessed using the oxygen-sensitive probe pimonidazole. The diabetic retinal microvasculature displayed decreases in red blood cell velocity (30%, p<0.001), shear rate (25%, p<0.01), and flow rate (40%, p<0.001). Moreover, transient capillary stoppages in flow were observed in the diabetic mice, but rarely in the non-diabetic mice. However, no alterations were observed in retinal hypoxia as determined by a pimonidazole assay, suggesting the possibility that the decreases seen in retinal blood flow may be dictated by a decrease in retinal oxygen utilization.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440813      PMCID: PMC3340465          DOI: 10.1016/j.exer.2012.03.003

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  49 in total

Review 1.  Update on the treatment of diabetic retinopathy.

Authors:  Jason C S Yam; Alvin K H Kwok
Journal:  Hong Kong Med J       Date:  2007-02       Impact factor: 2.227

2.  Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics.

Authors:  Zhongli Wang; Amit Singh Yadav; Wendy Leskova; Norman R Harris
Journal:  Exp Eye Res       Date:  2011-05-30       Impact factor: 3.467

3.  Role of angiotensin II in retinal leukostasis in the diabetic rat.

Authors:  Ping Chen; Gloria M Scicli; Meng Guo; Joseph D Fenstermacher; David Dahl; Paul A Edwards; A Guillermo Scicli
Journal:  Exp Eye Res       Date:  2006-07-05       Impact factor: 3.467

4.  Increase in retinal hypoxia-inducible factor-2α, but not hypoxia, early in the progression of diabetes in the rat.

Authors:  William S Wright; Robert M McElhatten; Norman R Harris
Journal:  Exp Eye Res       Date:  2011-06-15       Impact factor: 3.467

5.  Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract.

Authors:  Nancy M Holekamp; Ying-Bo Shui; David Beebe
Journal:  Am J Ophthalmol       Date:  2006-06       Impact factor: 5.258

6.  Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina.

Authors:  Jun-Won Park; Sung-Jin Park; Sun-Hwa Park; Keun-Young Kim; Jin-Woong Chung; Myung-Hoon Chun; Su-Ja Oh
Journal:  Neurobiol Dis       Date:  2005-07-14       Impact factor: 5.996

7.  Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration.

Authors:  Tanyth E de Gooyer; Kathryn A Stevenson; Pete Humphries; David A C Simpson; Tom A Gardiner; Alan W Stitt
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

Review 8.  Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?

Authors:  T M Curtis; T A Gardiner; A W Stitt
Journal:  Eye (Lond)       Date:  2009-05-15       Impact factor: 3.775

9.  Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.

Authors:  Jingfa Zhang; Yalan Wu; Ying Jin; Fei Ji; Stephen H Sinclair; Yan Luo; Guoxu Xu; Luo Lu; Wei Dai; Myron Yanoff; Weiye Li; Guo-Tong Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

10.  Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.

Authors:  Ermelindo C Leal; Ayyakkannu Manivannan; Ken-Ichi Hosoya; Tetsuya Terasaki; José Cunha-Vaz; António Francisco Ambrósio; John V Forrester
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

View more
  19 in total

1.  Decreased retinal blood flow in experimental colitis; improvement by eye drop administration of losartan.

Authors:  Megan N Watts; Randa S Eshaq; Patsy R Carter; Norman R Harris
Journal:  Exp Eye Res       Date:  2013-07-02       Impact factor: 3.467

2.  Vascular morphology and blood flow signatures for differential artery-vein analysis in optical coherence tomography of the retina.

Authors:  Tae-Hoon Kim; David Le; Taeyoon Son; Xincheng Yao
Journal:  Biomed Opt Express       Date:  2020-12-15       Impact factor: 3.732

3.  Intravital video microscopy measurements of retinal blood flow in mice.

Authors:  Norman R Harris; Megan N Watts; Wendy Leskova
Journal:  J Vis Exp       Date:  2013-12-26       Impact factor: 1.355

4.  n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models.

Authors:  Aruna Gorusupudi; Fu-Yen Chang; Kelly Nelson; Gregory S Hageman; Paul S Bernstein
Journal:  Mol Nutr Food Res       Date:  2019-06-28       Impact factor: 5.914

5.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

6.  Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy.

Authors:  Zongchao Han; Junjing Guo; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

7.  Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy.

Authors:  Rajendra Narayan Mitra; Chance A Nichols; Junjing Guo; Rasha Makkia; Mark J Cooper; Muna I Naash; Zongchao Han
Journal:  J Control Release       Date:  2016-06-11       Impact factor: 9.776

8.  Targeted overexpression of endothelial nitric oxide synthase in endothelial cells improves cerebrovascular reactivity in Ins2Akita-type-1 diabetic mice.

Authors:  Saurav B Chandra; Sumathy Mohan; Bridget M Ford; Lei Huang; Preethi Janardhanan; Kaiwalya S Deo; Linlin Cong; Eric R Muir; Timothy Q Duong
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-26       Impact factor: 6.200

9.  Measurement of retinal blood flow rate in diabetic rats: disparity between techniques due to redistribution of flow.

Authors:  Wendy Leskova; Megan N Watts; Patsy R Carter; Randa S Eshaq; Norman R Harris
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-26       Impact factor: 4.799

Review 10.  Animal models of diabetic retinopathy: summary and comparison.

Authors:  Angela Ka Wai Lai; Amy C Y Lo
Journal:  J Diabetes Res       Date:  2013-10-27       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.